Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approachesMichael Orth(LMU Klinikum), Kirsten Lauber(German Cancer Research Center)Radiation OncologyAugust 8, 201910.1186/s13014-019-1345-6Cited by 484SaveCiteExport RISWatch citationsRelated PapersCombination of 5-Fluorouracil with Epigenetic Modifiers Induces Radiosensitization, Somatostatin Receptor 2 Expression, and Radioligand Binding in Neuroendocrine Tumor Cells In Vitro|Journal of Nuclear Medicine|2019|46Procoagulant platelets promote immune evasion in triple-negative breast cancer|Blood|2024|33A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer|Oncotarget|2016|24